Business
Burcon Closes Final Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million
Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the closing of the final tranche of its previously announced non-brokered private placement (see news releases of the Company dated January 2, 2026, January 9, 2026 and February 27, 2026) of convertible debentures (the "Convertible Debentures") for an aggregate...
About this update from Burcon Nutrascience Corporation
[{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the closing of the final tranche of its previously announced non-brokered private placement (see news releases of the Company dated January 2, 2026, January 9, 2026 and February 27, 2026) of convertible debentures (the "Convertible Debentures") for an aggregate principal amount of $6.9 million (the "Private Placement").","length":607,"tagName":"p"},{"type":"text","content":"Under the final tranche, Burcon issued Convertible Debentures in the aggregate principal amount of $2.9 million. An insider of the Company subscribed for Convertible Debentures totaling approximately $1.7 million in principal amount under the final tranche. In total, insiders of the Company subscribed for Convertible Debentures totaling approximately $4.4 million in principal amount in aggregate under the Private Placement.","length":427,"tagName":"p"},{"type":"text","content":"With this closing, the Company has secured the full targeted proceeds of the financing, further strengthening its balance sheet and providing additional capital to support continued commercial growth. Importantly, insiders and key long-term investors represented a significant portion of the financing, underscoring continued confidence in Burcon's operating momentum, commercial progress, and long-term growth strategy. "Closing the final tranche of this financing and achieving our full $6.9 million target is an important milestone for Burcon," said Kip Underwood, Chief Executive Officer. "The strong participation from insiders and key investors reflects confidence in the momentum we are building and the progress we are making against our plan. With this capital in place, we are well positioned to support growing customer demand and continue executing our commercialization strategy."Convertible Debentures Details","length":951,"tagName":"p"},{"type":"text","content":"The Convertible Debentures terms of the Private Placement are set out in the Company's news release dated January 2, 2026. The Company did not pay any finder's fee in connection with the Private Placement.","lengt...